Algert Global LLC Sells 104,738 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
Algert Global LLC lowered its position in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 73.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 38,296 shares of the biopharmaceutical company’s stock after selling 104,738 shares during the quarter. Algert Global LLC’s holdings in Sage Therapeutics were worth $208,000 at the end of […]
